US4644959A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of functional assessment of cancer humoral factors
Assignee: Individual
•
Filing: 1984-11-01
•
Granted: 1987-02-24
•
Expires: 2004-11-01
Abstract
Abstract Improved cancer diagnostics are achieved by initially stimulating the neuromuscular junction of an amphibian to inactivate same synatic units and lower the functional safety margin of the other synaptic units. The amphibian is then injected with the serum of a cancer patient and further stimulated to elicit an cancer electromyographically evoked pattern. The pattern may be used as a diagnostic aid or for the detection and isolation of cancer humoral products having biological activity.
Inventors
- 👤 Sergiu Calmanovici
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 20:29
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/48; A; A61; A61B; A61B10/00
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
99 words
A method of identifying cancer in a suspected cancer patient, comprising the steps of: electrically stimulating the neuromuscular junction of a multiple-innervated muscle of a vertebrate; injecting said vertebrate with the serum of a suspected cancer patient while continuing said electrical stimulating step; varying the frequency, intensity and duration of said stimulation to obtain an electromyographical pattern determining the presence or absence of cancer electromyographically evoked activity; whereby the presence of said cancer electromyographically evoked activity is a positive indication of the presence in the patient of a serum factor only produced when the patient has a cancerous condition.
Claim 2
Independent Claim
99 words
A method of identifying cancer in a suspected cancer patient, comprising the steps of: electrically stimulating the neuromuscular junction of a multiple-innervated muscle of a vertebrate; injecting said vertebrate with the serum of a suspected cancer patient while continuing said electrical stimulating step; varying the frequency, intensity and duration of said stimulation to obtain an electromyographical pattern determining the presence or absence of cancer electromyographically evoked activity; whereby the presence of said cancer electromyographically evoked activity is a positive indication of the presence in the patient of a serum factor only produced when the patient has a cancerous condition.
Claim 3
Dependent Claim
11 words
The method of claim 1 wherein said vertebrate is an amphibian.
Claim 4
Dependent Claim
15 words
The method of claim 2 wherein said neuromuscular junction is that of the gastrocnemius muscle.
Claim 5
Dependent Claim
37 words
The method of claim 2 wherein said initial stimulation is of about 0.05 msec duration and a frequency of about 1 c/s and comprising continuing said initial stimulation for about 10 minutes prior to said injection step.
Claim 6
Dependent Claim
32 words
The method of claim 4 comprising injecting about 0.5-1 cc of said serum into the dorsal lymphatic sack of said amphibian injected at an approximately constant rate over about five minutes time.
Claim 7
Dependent Claim
18 words
The method of claim 5 wherein said amphibian is selected from the group consisting of frogs and toads.
Claim 8
Independent Claim
94 words
A method of performing a bioassay of a cancer humoral factor in a serum, comprising the steps of: electrically stimulating the neuromuscular junction of a multiple-innervated muscle of a vertebrate; injecting said vertebrate with a sample of said serum of while continuing said electrical stimulating step; varying the frequency, intensity and duration of said stimulation to obtain an electromyographical pattern; determining the presence or absence of cancer electromyographically evoked activity; whereby the presence of said cancer electromyographically evoked activity is a positive indication of the presence in the serum of a cancer humoral factor.
Claim 9
Independent Claim
94 words
A method of performing a bioassay of a cancer humoral factor in a serum, comprising the steps of: electrically stimulating the neuromuscular junction of a multiple-innervated muscle of a vertebrate; injecting said vertebrate with a sample of said serum of while continuing said electrical stimulating step; varying the frequency, intensity and duration of said stimulation to obtain an electromyographical pattern; determining the presence or absence of cancer electromyographically evoked activity; whereby the presence of said cancer electromyographically evoked activity is a positive indication of the presence in the serum of a cancer humoral factor.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-02-23 | 1990-08-25 | 1991-02-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-02-23 | 1994-08-25 | 1995-02-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-02-23 | 1998-08-25 | 1999-02-24 | $7700.00 | Window Closed / Lapsed |